BioNTech-Pfizer vaccine | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 16, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 16, 2025

BioNTech-Pfizer vaccine

Photo: Collected
Health

Cancer vaccine may be ready by 2030, say founders of Covid-19 vaccine maker BioNTech

The World Health Organization logo is pictured at the entrance of the WHO building, in Geneva, Switzerland, December 20, 2021. Photo :Reuters
Coronavirus chronicle

WHO advisory panel recommends extending use of Pfizer vaccine to 5-11 year olds

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Israel sees probable link between Pfizer vaccine and myocarditis cases

Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech Covid-19 vaccinations at the Haus an der Linde nursing home in Lichtentanne, Saxony, Germany December 27, 2020, the day when the country starts its vaccination programme. Hendrik Schmidt/Pool via Reuters
Coronavirus chronicle

Singapore begins rollout of Pfizer's Covid-19 vaccine with healthcare workers

A bottle of Pfizer/BioNTech vaccine against the coronavirus disease (Covid-19) is pictured as the first batch is being defrosted at the Gasthuisberg hospital in Leuven, Belgium December 27, 2020. Fred Sierakowski/Pool via REUTERS
Coronavirus chronicle

Pfizer delayed delivery of new batch of vaccine to Spain by one day

Photo: Collected.
Coronavirus chronicle

Bahrain grants emergency use for Pfizer, BioNTech Covid-19 vaccine

Photo: A construction worker passes a a sign thanking the NHS at the entrance to the HS2 site at London Euston, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Toby Melville
Coronavirus chronicle

UK healthcare staff no longer top priority for Covid vaccine 

Photo: Collected.
Coronavirus chronicle

UK approves Pfizer-BioNTech vaccine for use

Photo: Collected.
Coronavirus chronicle

England hospitals instructed to prepare Pfizer vaccine rollout in 10 days’ time 

The question arises whether a member state would want to administer to its citizens a vaccine that has not been reviewed by EMA

Photo: Collected
Coronavirus chronicle

Covid-19 vaccine: The next steps

Photo: Collected.
Coronavirus chronicle

EU could pay over $10 billion for Pfizer and CureVac vaccines 

Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
Analysis

Airlines scramble to prepare for ultra-cold Covid-19 vaccine distribution

The question arises whether a member state would want to administer to its citizens a vaccine that has not been reviewed by EMA

Photo: Collected
Coronavirus chronicle

How two companies sprinted ahead in extraordinary race for a Covid vaccine

  • Show More
  • loading...
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net